GMP Compliance in Tablet Coating | Pharma Quality Guide

GMP Compliance in Tablet Coating: A Practical Guide for Pharma Manufacturers

In the pharmaceutical industry, film coating is not merely an aesthetic process; it is a critical manufacturing step that directly impacts drug safety, efficacy, and shelf-life stability. Consequently, the coating unit operation is heavily scrutinized by regulatory authorities such as the US FDA, EMA, and WHO. Maintaining strict Good Manufacturing Practice (GMP) compliance is essential to eliminate audit 483 observations, warning letters, and costly batch rejections.

Here is a practical, step-by-step overview of GMP requirements for oral solid dosage tablet coating.

1. Raw Material Qualification & Vendor Audits

GMP compliance begins long before the polymer enters the coating pan. Every excipient used in your formulation—including polymers (HPMC, PVA), plasticizers, opacifiers, and color pigments—must be rigorously qualified. Pharmaceutical companies must verify that their excipient suppliers operate under certified Quality Management Systems (QMS). Learn more about our cGMP quality infrastructure and testing standards. Regular supplier audits must verify that raw materials are fully compliant with current pharmacopeial monographs (USP/NF, EP, BP, JP) and backed by complete BSE/TSE and elemental impurity risk assessments.

2. Facility and Equipment Validation (IQ/OQ/PQ)

Your coating facility must be engineered to prevent cross-contamination. This involves maintaining dedicated cleanroom suites and classified HVAC systems (ISO 8 or Class 100,000) to control airborne particulate matter and relative humidity. Furthermore, coating equipment—including perforated pans, spray guns, peristaltic pumps, and air handling units—must undergo formal validation: Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). Calibration of RTD temperature sensors, airflow anemometers, and load cells is mandatory to ensure all thermodynamic process variables are documented accurately.

3. In-Process Quality Control (IPQC)

Coating is a dynamic thermodynamic balance between spray rate and moisture evaporation. Under GMP guidelines, manufacturers must establish and validate Critical Process Parameters (CPPs) such as inlet/exhaust air temperatures, atomization air pressure, pan speed, and peristaltic flow rate.

During the coating run, QA and production personnel must perform routine In-Process Quality Checks (IPQC). Key checkpoints include tablet weight gain percentage, film adhesion testing, friability evaluation, core hardness, and visual inspection for defects such as sticking, twinning, or orange peel. If any visual defects emerge during processing, consult our coating defect troubleshooting matrix to enact immediate corrective action within validated tolerances.

4. Batch Documentation, Traceability & Data Integrity

The core principle of GMP is: "If it is not documented, it did not happen." Every step of the coating process must be captured in the Electronic Batch Manufacturing Record (EBMR). This includes exact excipient weighings, dispensing slips, reconstitution mixing speeds, cleaning logs, environmental monitoring data, and double-operator electronic signatures. Complete lot traceability ensures rapid root-cause analysis during unexpected deviations.

Partnering for Regulatory Confidence

Navigating evolving regulatory standards requires an experienced, dependable partner. ANSHCOAT supports your compliance efforts by providing highly consistent, regulatory-compliant tablet film coating systems backed by audit-ready Drug Master Files (DMFs), Certificates of Analysis, and validation documentation. Need regulatory support or audit questionnaires? Contact our QA team or request qualification samples for upcoming product validations.